mitral regurgitation

(redirected from mitral insufficiency)
Also found in: Thesaurus, Medical, Legal, Wikipedia.
Related to mitral insufficiency: aortic stenosis, mitral stenosis, mitral valve prolapse, aortic insufficiency, Mitral valve insufficiency, tricuspid insufficiency

mitral regurgitation

n.
The backward flow of blood from the left ventricle into the left atrium of the heart, caused by incompetent closure of the mitral valve. Also called mitral insufficiency.
Translations

mi·tral re·gur·gi·ta·tion

n. regurgitación mitral, flujo sanguíneo retrógrado del ventrículo izquierdo a la aurícula izquierda causado por lesión de la válvula mitral.
References in periodicals archive ?
They focus on medical treatments for atrial septal defects (ASD), ventricular septal defects (VSD), patent foramen ovales (PFO), and mitral insufficiency.
Aortic and/or mitral insufficiency were detected in 2 children and accepted as rheumatic heart disease.
TOKYO - Prince Mikasa, an uncle of Emperor Akihito, was admitted to a Tokyo hospital Thursday after being diagnosed as suffering from acute left heart failure stemming from mitral insufficiency, the Imperial Household Agency said.
We think that the flow-jet of mitral insufficiency selectively directed toward the right upper pulmonary vein might be causing right-sided UPE in our patient.
Improvement in symptoms and left ventricular function along with a very low mortality risk justifies strong consideration to offering mitral valve surgery in combination with a CSD to nonischemic heart failure patients who've been medically optimized yet remain symptomatic with significant mitral insufficiency," said Dr.
Mitral Regurgitation (MR), mitral insufficiency or mitral incompetence, the most common type of heart valve disorder, occurs when the heart's mitral valve does not close properly, resulting in an inadequate blood flow to the body.
Using an LOCF analysis for each year, the assessment of echocardiograms performed at baseline and after patients completed 6, 12, 18 and 24 months of dosing indicated that lorcaserin was not associated with valvular insufficiency: during two years of use, rates of change in individual regurgitant scores and the development of FDA-defined valvulopathy (moderate or greater mitral insufficiency and/or mild or greater aortic insufficiency) were similar between treatment groups.
To the Editor: In their article outlining potential consequences of postpartum hemodynamics in mitral insufficiency, Khanlou et al (1) rightly underscored the importance of puerperal increases in systemic vascular resistance (SVR).